ไทย
简体中文
CardioMed Pharmacogenomic Panel – Genetic Testing for Drug Response and Sensitivity in Cardiovascular Disease
How can you be sure that the heart medication you are taking is the most suitable for you? The CardioMed Pharmacogenomic Panel analyses genes that affect drug response, providing your doctor with the information needed to choose the right medication at the right dose specifically for your genetic profile. This helps optimise treatment efficacy, reduce the risk of side effects, and supports truly personalised cardiovascular care.
What is this screening?
It is a pharmacogenetic (PGx) test that analyses the relationship between your genetic makeup and your body’s response to medications, enabling the optimisation of drug therapy for each individual.
Pharmacogenetic Testing for Cardiovascular Disease
Genetic testing for cardiovascular-related drugs helps identify how your body metabolises and responds to specific medications — allowing doctors to tailor treatments for greater safety and effectiveness.
Cardiovascular drugs
Clopidogrel (CYP2C19)
Anti-arrhythmic and anti-hypertensive drugs
Flecainide, Propafenone (CYP2D6)
Anticoagulants
Warfarin (CYP2C9, VKORC1, CYP4F2)
Lipid-lowering agents
Atorvastatin, Rosuvastatin, Simvastatin (SLCO1B1, CYP2C9, ABCG2)
Comprehensive Pharmacogenetic Testing for Drug Hypersensitivity
Pharmacogenetics for HLA-B Genotyping with HLA-A*31:01
This genetic test identifies HLA-B and HLA-A gene variants associated with severe adverse drug reactions, enabling safer and more personalised medication use.
Anti-gout medication
Allopurinol (HLA-B*58:01)
Anticonvulsant medications
Carbamazepine, Oxcarbazepine (HLA-B15:02, HLA-A31:01, B75 serotype)
Phenytoin, Fosphenytoin (HLA-B*15:02)
Lamotrigine (HLA-B*15:02)
Important Information
- Recommended frequency: once in a lifetime.
Service Procedure
- Please make an appointment at least two days in advance via Line @BNHhospital, by email at [email protected], or by calling 02-0220700 ext. 2847, 4445–7 during the hours of 13:00–15:00 only.
- Once your request has been received, the Health Check-up Department will contact you between 13:00–15:00 or by email to confirm your appointment.
- If you need to reschedule, kindly inform us at least two days in advance, again during 13:00–15:00 only.
- The screening service is provided at the Advanced Diagnostic Centre, 4th Floor, Zone A, BNH Hospital. On the day of your visit, our staff will first provide information about the test.
- Fasting is not required, and you should inform your doctor of all medications you are currently taking.
- The sample will be analysed in the laboratory, with results available in approximately 16 days.
- You will meet with a doctor to review the screening report, which will indicate any potential risk signals for various cancers and guide the planning of further diagnostic examinations
- In cases where a positive result is found, a specialist will provide additional consultation and recommend specific diagnostic procedures.
Frequently Asked Questions (FAQ) about CardioMed Pharmacogenomic Panel
A: It suits people taking, or about to start, cardiovascular medications who want to understand their genetic response to these drugs, helping doctors choose the right type and dose and reduce side effects.
A: It uses a blood sample with no fasting required; bring your current medication list to aid interpretation.
A: Results are available within a few weeks and show how your body responds to and metabolizes various heart medications for personalized treatment.
A: Yes. Physicians and specialists are available to explain your results and next steps. You can book an appointment at BNH Hospital via the website or by phone.
